Financial Statements · From SEC 10-K & 10-Q XBRL Filings
HCA Healthcare Inc. Revenue & Financial Statements
HCA Healthcare Inc. reported revenue of $75.6B for the fiscal year ended December 31, 2025, up 7.1% year over year, with net income of $7.8B and diluted EPS of $28.33.
- Company
- HCA Healthcare Inc. HCA · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 58.8B | 60.2B | 65.0B | 70.6B | 75.6B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | 9.8B | 8.6B | 7.7B | 8.5B | 9.8B |
| Net income | 7.0B | 5.6B | 5.2B | 5.8B | 7.8B |
| Diluted EPS | 21.16 | 19.15 | 18.97 | 22.00 | 28.33 |
| EBITDA | — | — | — | — | — |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.3B | 17.5B | 17.5B | 18.3B | 18.3B | 18.6B | 19.2B | 19.5B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Pretax income | 2.2B | 2.2B | 1.9B | 2.1B | 2.3B | 2.4B | 2.4B | 2.7B |
| Net income | 1.6B | 1.5B | 1.3B | 1.4B | 1.6B | 1.7B | 1.6B | 2.2B |
| Diluted EPS | 5.93 | 5.53 | 4.88 | 5.63 | 6.45 | 6.83 | 6.96 | 8.10 |
| EBITDA | — | — | — | — | — | — | — | — |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 50.7B | 52.4B | 56.2B | 59.5B | 60.7B |
| Current assets | 13.5B | 13.6B | 14.9B | 16.4B | 15.8B |
| Cash & equivalents | 1.5B | 908.0M | 935.0M | 1.9B | 1.0B |
| Total liabilities | — | — | — | — | — |
| Current liabilities | 9.6B | 9.9B | 12.7B | 15.2B | 16.4B |
| Long-term debt | 34.3B | 37.7B | 37.2B | 38.3B | 41.6B |
| Total debt | 34.6B | 38.1B | 39.6B | 43.0B | 41.6B |
| Stockholders’ equity | (933.0M) | (2.8B) | (1.8B) | (2.5B) | (6.0B) |
| Net debt | 33.1B | 37.2B | 38.7B | 41.1B | 40.6B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 9.0B | 8.5B | 9.4B | 10.5B | 12.6B |
| Investing cash flow | (2.6B) | (3.4B) | (5.3B) | (4.9B) | (5.0B) |
| Financing cash flow | (6.7B) | (5.7B) | (4.1B) | (4.6B) | (8.6B) |
| Capital expenditure | 3.6B | 4.4B | 4.7B | 4.9B | 4.9B |
| Free cash flow | 5.4B | 4.1B | 4.7B | 5.6B | 7.7B |
| Dividends paid | 624.0M | 653.0M | 661.0M | 690.0M | 679.0M |
| Stock-based compensation | 440.0M | 341.0M | 262.0M | 360.0M | 401.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every HCA filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.